As of now, alpha‐fetoprotein (AFP) is the most employed clinical biomarker for the HCC diagnosis; however, the diagnostic sensitivity of this biomarker remains relatively low, at approximately 60%.6 The gene discussed is AFP; the disease is hepatocellular carcinoma.